Gene therapy startup Lexeo, inflammatory biotech Abivax submit Nasdaq listing plansnews2023-09-29T20:44:49+00:00September 29th, 2023|Endpoints News|
Sen. Bill Cassidy calls on hospitals to provide more information on how they use 340B fundsnews2023-09-29T19:24:07+00:00September 29th, 2023|Endpoints News|
FDA rolls out long-awaited proposal to overhaul diagnostics regulationnews2023-09-29T18:49:11+00:00September 29th, 2023|Endpoints News|
FDA unveils new rare disease pilot program to increase agency-sponsor communicationsnews2023-09-29T18:47:57+00:00September 29th, 2023|Endpoints News|
GSK’s ViiV Healthcare set to launch second season of LGBTQ+ Latinx ‘telenovela-style’ podcast with celeb voicesnews2023-09-29T18:39:10+00:00September 29th, 2023|Endpoints News|
Independent pharma and healthcare ad agency The Bloc takes its business around the worldnews2023-09-29T18:34:55+00:00September 29th, 2023|Endpoints News|
Madrigal raises $500M for NASH drug launch, discloses cyberattacknews2023-09-29T15:06:50+00:00September 29th, 2023|Endpoints News|
In the race to get type 1 patients off insulin, focus turns to cell transplants and insulin-producing stem cellsnews2023-09-29T14:55:26+00:00September 29th, 2023|Endpoints News|
How Endpoints News will cover the future of the healthcare industrynews2023-09-29T14:42:27+00:00September 29th, 2023|Endpoints News|
Merck KGaA’s expanded AI deal; Ascletis has new biomarker data for its PD-L1; Deka closes $20M roundnews2023-09-29T14:17:57+00:00September 29th, 2023|Endpoints News|
